Tenet Healthcare Corporation $THC Stake Cut by NewEdge Advisors LLC

NewEdge Advisors LLC trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 64.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,180 shares of the company’s stock after selling 11,178 shares during the period. NewEdge Advisors LLC’s holdings in Tenet Healthcare were worth $1,166,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Jones Financial Companies Lllp lifted its holdings in Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC acquired a new stake in shares of Tenet Healthcare during the 2nd quarter worth approximately $290,000. Quantbot Technologies LP bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth approximately $65,000. Amundi boosted its position in Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the period. Finally, Jump Financial LLC acquired a new stake in Tenet Healthcare in the second quarter worth $1,083,000. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 10,878 shares of Tenet Healthcare stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $243.90, for a total value of $2,653,144.20. Following the transaction, the executive vice president owned 18,413 shares of the company’s stock, valued at $4,490,930.70. The trade was a 37.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 41,375 shares of company stock valued at $9,793,347. Corporate insiders own 0.97% of the company’s stock.

Analyst Ratings Changes

THC has been the subject of several analyst reports. Raymond James Financial reissued an “outperform” rating and set a $285.00 price target on shares of Tenet Healthcare in a report on Friday. Guggenheim boosted their target price on shares of Tenet Healthcare from $242.00 to $283.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. KeyCorp dropped their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Mizuho set a $290.00 price objective on Tenet Healthcare in a research report on Monday, August 10th. Finally, Piper Sandler set a $308.00 target price on Tenet Healthcare in a research report on Monday, July 27th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $273.00.

Tenet Healthcare Stock Down 1.0%

THC stock opened at $265.18 on Tuesday. The firm’s 50-day moving average is $212.24 and its two-hundred day moving average is $204.56. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The company has a market capitalization of $21.35 billion, a price-to-earnings ratio of 10.23, a price-to-earnings-growth ratio of 1.02 and a beta of 1.23. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $270.57.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion during the quarter, compared to the consensus estimate of $5.43 billion. During the same period in the prior year, the firm posted $4.02 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, analysts forecast that Tenet Healthcare Corporation will post 20.97 earnings per share for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.